Kenvue Inc (KVUE)

$17.49 0.00 (N/A)
Market Cap 33.58B
Revenue (ttm) 15.12B
Net Income (ttm) 1.47B
EPS (ttm) N/A
PE Ratio 16.19
Forward PE 15.88
Profit Margin 9.72%
Debt to Equity Ratio 0.66
Volume 6,581,400
Avg Vol 25,155,584
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 54%
Beta 0.61
Analysts Sell
Price Target $19.09

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 908 874 1200
Address:
1 Kenvue Way, Summit, United States
StockWatch4
StockWatch4 Apr. 26 at 8:21 AM
$KVUE consumer healthcare company with defensive earnings and strong brand stability
0 · Reply
DragonAlgo
DragonAlgo Apr. 26 at 8:08 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.23 Stop: $0.17 TP1: $0.30 TP2: $0.39 TP3: $0.55 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Apr. 25 at 4:04 AM
$KVUE $KMB still one of my favorite blue chips. There arent many single stocks out there that provide the consistency and dividend rate. Selling calls + dividend.
0 · Reply
TonyG6ix
TonyG6ix Apr. 24 at 6:00 PM
$KVUE in it, have a couple of short puts expiring today.
0 · Reply
DragonAlgo
DragonAlgo Apr. 24 at 3:51 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.23 Stop: $0.17 TP1: $0.31 TP2: $0.40 TP3: $0.56 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Apr. 23 at 9:19 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.25 Stop: $0.18 TP1: $0.33 TP2: $0.42 TP3: $0.60 🔗 https://dragonalgo.com
0 · Reply
Candleclosekinghq
Candleclosekinghq Apr. 23 at 4:23 PM
$KVUE 17.5 CALL 04/24 @0.17 #KVUE
0 · Reply
Candleclosekinghq
Candleclosekinghq Apr. 23 at 4:18 PM
Watching $KVUE 17.5 CALL 04/24 SO close to being itm. Should go green quick for us
0 · Reply
DragonAlgo
DragonAlgo Apr. 23 at 2:52 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $25.00 | Type: CALL Option Plan (premium): Entry: $0.13 Stop: $0.09 TP1: $0.17 TP2: $0.22 TP3: $0.31 🔗 https://dragonalgo.com
0 · Reply
25yrgold
25yrgold Apr. 22 at 7:11 PM
$KVUE
0 · Reply
Latest News on KVUE
Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Apr 23, 2026, 4:32 PM EDT - 2 days ago

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

Apr 15, 2026, 10:01 AM EDT - 10 days ago

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

KMB

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

Apr 15, 2026, 9:52 AM EDT - 10 days ago

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

KMB

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

Apr 15, 2026, 8:55 AM EDT - 10 days ago

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

KMB

Tylenol in pregnancy not linked with autism, Danish study finds

Apr 13, 2026, 2:09 PM EDT - 12 days ago

Tylenol in pregnancy not linked with autism, Danish study finds

Tylenol use among women dropped after Trump tied it to autism

Mar 6, 2026, 12:43 PM EST - 7 weeks ago

Tylenol use among women dropped after Trump tied it to autism

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Feb 26, 2026, 11:14 AM EST - 2 months ago

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:50 PM EST - 2 months ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

Feb 17, 2026, 5:42 PM EST - 2 months ago

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

KMB

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:45 PM EST - 2 months ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Feb 4, 2026, 6:45 AM EST - 2 months ago

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

Jan 29, 2026, 9:27 AM EST - 3 months ago

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

KMB

Kenvue Transcript: AGM 2026

Jan 29, 2026, 9:00 AM EST - 3 months ago

Kenvue Transcript: AGM 2026

Kenvue Declares Quarterly Cash Dividend

Jan 28, 2026, 6:45 AM EST - 3 months ago

Kenvue Declares Quarterly Cash Dividend

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

Jan 27, 2026, 6:40 AM EST - 3 months ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

Jan 16, 2026, 6:32 PM EST - 3 months ago

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

Jan 16, 2026, 10:00 AM EST - 3 months ago

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

KMB

US appeals court to weigh reviving cases over Tylenol and autism

Nov 17, 2025, 6:07 AM EST - 5 months ago

US appeals court to weigh reviving cases over Tylenol and autism

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Nov 14, 2025, 12:42 PM EST - 5 months ago

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Nov 14, 2025, 6:05 AM EST - 5 months ago

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 6 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

Nov 4, 2025, 2:26 PM EST - 6 months ago

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

IYK KMB VDC XLP

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

Nov 3, 2025, 10:00 PM EST - 6 months ago

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

KMB

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

Nov 3, 2025, 7:11 PM EST - 6 months ago

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

KMB

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Nov 3, 2025, 6:40 PM EST - 6 months ago

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

KMB

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

Nov 3, 2025, 5:20 PM EST - 6 months ago

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

KMB

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

Nov 3, 2025, 5:15 PM EST - 6 months ago

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

AMZN KMB

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

Nov 3, 2025, 4:58 PM EST - 6 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

KMB

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

Nov 3, 2025, 4:39 PM EST - 6 months ago

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

KMB

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

Nov 3, 2025, 4:01 PM EST - 6 months ago

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

KMB

Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 6 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

Nov 3, 2025, 12:37 PM EST - 6 months ago

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

KMB

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Nov 3, 2025, 12:01 PM EST - 6 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

KMB

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Nov 3, 2025, 11:40 AM EST - 6 months ago

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

KMB

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 6 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Nov 3, 2025, 10:44 AM EST - 6 months ago

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

KMB

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

Nov 3, 2025, 10:33 AM EST - 6 months ago

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

KMB

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

Nov 3, 2025, 9:57 AM EST - 6 months ago

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

KMB

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Nov 3, 2025, 9:30 AM EST - 6 months ago

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Nov 3, 2025, 9:16 AM EST - 6 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

KMB

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

Nov 3, 2025, 9:15 AM EST - 6 months ago

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

KMB

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

Nov 3, 2025, 8:40 AM EST - 6 months ago

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

KMB

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

Nov 3, 2025, 8:27 AM EST - 6 months ago

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

KMB

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

Nov 3, 2025, 8:24 AM EST - 6 months ago

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

KMB

Kenvue Transcript: M&A Announcement

Nov 3, 2025, 8:00 AM EST - 6 months ago

Kenvue Transcript: M&A Announcement

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

Nov 3, 2025, 7:49 AM EST - 6 months ago

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

KMB

Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion

Nov 3, 2025, 6:50 AM EST - 6 months ago

Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion

KMB

Kimberly-Clark to Buy Tylenol Maker Kenvue

Nov 3, 2025, 6:44 AM EST - 6 months ago

Kimberly-Clark to Buy Tylenol Maker Kenvue

KMB

Kenvue Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 9 months ago

Kenvue Earnings Call Transcript: Q2 2025

Kenvue Transcript: 2025 dbAccess Global Consumer Conference

Jun 3, 2025, 6:00 AM EDT - 11 months ago

Kenvue Transcript: 2025 dbAccess Global Consumer Conference

Kenvue Transcript: AGM 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Kenvue Transcript: AGM 2025

Kenvue Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Kenvue Earnings Call Transcript: Q1 2025

Kenvue Transcript: Consumer Analyst Group of New York Conference (CAGNY) 2025

Feb 19, 2025, 3:00 PM EST - 1 year ago

Kenvue Transcript: Consumer Analyst Group of New York Conference (CAGNY) 2025

Kenvue Earnings Call Transcript: Q4 2024

Feb 6, 2025, 8:00 AM EST - 1 year ago

Kenvue Earnings Call Transcript: Q4 2024

Kenvue Transcript: Morgan Stanley Global Consumer & Retail Conference

Dec 4, 2024, 11:45 AM EST - 1 year ago

Kenvue Transcript: Morgan Stanley Global Consumer & Retail Conference

Kenvue Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Kenvue Earnings Call Transcript: Q3 2024

Kenvue Transcript: Barclays 17th Annual Global Consumer Staples Conference

Sep 5, 2024, 3:00 PM EDT - 1 year ago

Kenvue Transcript: Barclays 17th Annual Global Consumer Staples Conference

Kenvue Earnings Call Transcript: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

Kenvue Earnings Call Transcript: Q2 2024

Kenvue Transcript: 2024 Deutsche Bank dbAccess Global Consumer Conference

Jun 4, 2024, 8:45 AM EDT - 2 years ago

Kenvue Transcript: 2024 Deutsche Bank dbAccess Global Consumer Conference

Kenvue Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Kenvue Earnings Call Transcript: Q1 2024

Kenvue Transcript: 2024 Consumer Analyst Group of New York Conference

Feb 23, 2024, 10:00 AM EST - 2 years ago

Kenvue Transcript: 2024 Consumer Analyst Group of New York Conference

Kenvue Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Kenvue Earnings Call Transcript: Q4 2023

Kenvue Transcript: Morgan Stanley Global Consumer & Retail Conference

Dec 6, 2023, 11:45 AM EST - 2 years ago

Kenvue Transcript: Morgan Stanley Global Consumer & Retail Conference

Kenvue Earnings Call Transcript: Q3 2023

Oct 26, 2023, 8:30 AM EDT - 2 years ago

Kenvue Earnings Call Transcript: Q3 2023

Kenvue Earnings Call Transcript: Q2 2023

Jul 20, 2023, 7:30 AM EDT - 3 years ago

Kenvue Earnings Call Transcript: Q2 2023

StockWatch4
StockWatch4 Apr. 26 at 8:21 AM
$KVUE consumer healthcare company with defensive earnings and strong brand stability
0 · Reply
DragonAlgo
DragonAlgo Apr. 26 at 8:08 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.23 Stop: $0.17 TP1: $0.30 TP2: $0.39 TP3: $0.55 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Apr. 25 at 4:04 AM
$KVUE $KMB still one of my favorite blue chips. There arent many single stocks out there that provide the consistency and dividend rate. Selling calls + dividend.
0 · Reply
TonyG6ix
TonyG6ix Apr. 24 at 6:00 PM
$KVUE in it, have a couple of short puts expiring today.
0 · Reply
DragonAlgo
DragonAlgo Apr. 24 at 3:51 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.23 Stop: $0.17 TP1: $0.31 TP2: $0.40 TP3: $0.56 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Apr. 23 at 9:19 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.25 Stop: $0.18 TP1: $0.33 TP2: $0.42 TP3: $0.60 🔗 https://dragonalgo.com
0 · Reply
Candleclosekinghq
Candleclosekinghq Apr. 23 at 4:23 PM
$KVUE 17.5 CALL 04/24 @0.17 #KVUE
0 · Reply
Candleclosekinghq
Candleclosekinghq Apr. 23 at 4:18 PM
Watching $KVUE 17.5 CALL 04/24 SO close to being itm. Should go green quick for us
0 · Reply
DragonAlgo
DragonAlgo Apr. 23 at 2:52 AM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $25.00 | Type: CALL Option Plan (premium): Entry: $0.13 Stop: $0.09 TP1: $0.17 TP2: $0.22 TP3: $0.31 🔗 https://dragonalgo.com
0 · Reply
25yrgold
25yrgold Apr. 22 at 7:11 PM
$KVUE
0 · Reply
PelagosGroup
PelagosGroup Apr. 22 at 5:36 PM
$KMB has beat earnings the last four quarters. Another beat + good guidance will lift $KVUE as well in my opinion, which will boost the closing merger value later this year. Not advice.
0 · Reply
DragonAlgo
DragonAlgo Apr. 22 at 8:11 AM
🐉 $KVUE PUT — DragonAlgo® Signal Contract: KVUE PUT Expiry: 2026-04-24 | Strike: $17.50 | Type: PUT Option Plan (premium): Entry: $0.24 Stop: $0.17 TP1: $0.31 TP2: $0.41 TP3: $0.58 Rules-based execution profile. 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Apr. 21 at 2:24 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $25.00 | Type: CALL Option Plan (premium): Entry: $0.13 Stop: $0.09 TP1: $0.17 TP2: $0.22 TP3: $0.31 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Apr. 20 at 6:06 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $18.00 | Type: CALL Option Plan (premium): Entry: $0.28 Stop: $0.20 TP1: $0.36 TP2: $0.47 TP3: $0.66 🔗 https://dragonalgo.com
0 · Reply
PelagosGroup
PelagosGroup Apr. 20 at 5:32 PM
$KVUE I asked A.I. for important dates/catalysts vis-a-vis $KVUE and $KMB . Good earnings + guidance could spark a nice rally.
0 · Reply
DragonAlgo
DragonAlgo Apr. 18 at 3:33 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $17.00 | Type: CALL Option Plan (premium): Entry: $0.86 Stop: $0.62 TP1: $1.12 TP2: $1.46 TP3: $2.06 🔗 https://dragonalgo.com
0 · Reply
WuTangClam
WuTangClam Apr. 17 at 10:51 PM
$KMB will my $KVUE shares that I'm up 22% on currently mess up my Kimberly average at 97$ when merger is complete? Not sure how that works. I know we get 3.50$ a share and bit of Kimberly clark. Just confused how that all works.
3 · Reply
DragonAlgo
DragonAlgo Apr. 17 at 12:54 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-04-17 | Strike: $17.50 | Type: CALL Option Plan (premium): Entry: $0.12 Stop: $0.09 TP1: $0.16 TP2: $0.20 TP3: $0.29 Volatility regime is active. 🔗 https://dragonalgo.com
0 · Reply
DragonAlgo
DragonAlgo Apr. 16 at 4:33 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-04-17 | Strike: $17.50 | Type: CALL Option Plan (premium): Entry: $0.11 Stop: $0.08 TP1: $0.15 TP2: $0.20 TP3: $0.28 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
mr_Apex
mr_Apex Apr. 16 at 2:25 PM
$KVUE 17 APR 26 $17.5 CALL $0.21‼️‼️ Looks good
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 16 at 2:36 AM
$KVUE RSI: 43.08, MACD: -0.1524 Vol: 0.20, MA20: 17.37, MA50: 17.91 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DragonAlgo
DragonAlgo Apr. 15 at 9:07 PM
🐉 $KVUE CALL — DragonAlgo® Signal Contract: KVUE CALL Expiry: 2026-05-15 | Strike: $25.00 | Type: CALL Option Plan (premium): Entry: $0.13 Stop: $0.09 TP1: $0.17 TP2: $0.22 TP3: $0.31 🔗 https://dragonalgo.com
0 · Reply